From cancer to HIV, these are some of the areas where CRISPR gene-editing drugs show the most promise, say scientists.
The concept of CRISPR gene-editing is still quite young. Although the discovery of CRISPRs themselves—repeating DNA sequences present in single-celled organisms, such as bacteria—can be traced back to the late 1980s, their use in more complex multi-celled organisms for the purposes of targeted gene-editing and the slicing-and-dicing of genetic code to combat diseases...